Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 10, 2004
Previous Article Next Article

Asymmetric synthesis of (4R,5R)-cytoxazone and (4R,5S)-epi-cytoxazone

Author affiliations

Abstract

(4R,5R)-Cytoxazone has been prepared in four steps and in 61% overall yield and >98% ee. Conjugate addition of lithium (R)-N-benzyl-N-α-methylbenzylamide to tert-butyl (E)-3-(p-methoxyphenyl)prop-2-enoate and subsequent in situ diastereoselective enolate oxidation with (+)-(camphorsulfonyl)oxaziridine gave tert-butyl (2R,3RR)-2-hydroxy-3-(p-methoxyphenyl)-3-(N-benzyl-N-α-methylbenzylamino)propanoate in >98% de. Subsequent N-benzyl deprotection to the primary β-amino ester via hydrogenolysis, oxazolidinone formation with C(2)-retention by treatment with diphosgene and chemoselective ester reduction furnishes (4R,5R)-cytoxazone. The synthesis of the C(5)-epimer, (4R,5S)-epi-cytoxazone in 44% overall yield, has also been completed via a protocol involving N-Boc protection of the primary β-amino ester, utilization of the N-Boc group to facilitate simultaneous C(2)-inversion and oxazolidinone formation, and subsequent reduction.

Graphical abstract: Asymmetric synthesis of (4R,5R)-cytoxazone and (4R,5S)-epi-cytoxazone

Back to tab navigation

Article information


Submitted
18 Feb 2004
Accepted
30 Mar 2004
First published
27 Apr 2004

Org. Biomol. Chem., 2004,2, 1549-1553
Article type
Paper

Asymmetric synthesis of (4R,5R)-cytoxazone and (4R,5S)-epi-cytoxazone

S. G. Davies, D. G. Hughes, R. L. Nicholson, A. D. Smith and A. J. Wright, Org. Biomol. Chem., 2004, 2, 1549
DOI: 10.1039/B402437K

Social activity

Search articles by author

Spotlight

Advertisements